UBS Group’s P3 Health Partners Inc Warrant PIIIW Stock Holding History

UBS Group’s Portfolio PIIIW Stock Details PIIIW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$10	Sell	1,964 -908	-32%	-$7	﹤0.01%	10328
2025 Q4	$29	Buy	+2,872	New	+$28	﹤0.01%	10324
2025 Q2	–	Sell	-514	Closed	-$5	–	10701
2025 Q1	$5	Sell	514 -100	-16%	-$2	﹤0.01%	10145
2024 Q4	$7	Buy	+614	New	+$11	﹤0.01%	9824
2024 Q3	–	Sell	-6,094	Closed	-$305	–	9927
2024 Q2	$305	Buy	+6,094	New	+$384	﹤0.01%	8988
2024 Q1	–	Sell	-339	Closed	-$36	–	9856
2023 Q4	$36	Buy	339 +209	+161%	+$25	﹤0.01%	9027
2023 Q3	$22	Sell	130 -2,828	-96%	-$617	﹤0.01%	9108
2023 Q2	$710	Buy	2,958 +958	+48%	+$196	﹤0.01%	8120
2023 Q1	$160	Buy	+2,000	New	+$236	﹤0.01%	9169

Other funds holding PIIIW

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

Athos Capital Hong Kong $324M AUM 16.62% 1-Year Est. Return

WAM

Warberg Asset Management Winnetka, Illinois $600M AUM 23.37% 1-Year Est. Return

StoneX Group New York $1.86B AUM 21.3% 1-Year Est. Return

MCM

Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return

PEAK6 Chicago, Illinois $42.6B AUM 66.3% 1-Year Est. Return

GCM

Greenland Capital Management New York $787M AUM 40.68% 1-Year Est. Return

TCM

Tenor Capital Management New York $6.49B AUM 3.01% 1-Year Est. Return

UBS Group's PIIIW Position: Q1 2026 in Review

UBS Group reduced its P3 Health Partners Inc Warrant (PIIIW) stake by 32% in Q1 2026, selling an estimated $7 and leaving 1,964 shares worth $10. The position accounts for ﹤0.01% of the portfolio, ranked #10328.

UBS Group first reported a position in PIIIW in Q1 2023 and has held it in 9 quarters since. The position peaked at $710 in Q2 2023. 19 funds tracked by Wall St. Rank hold PIIIW as of Q1 2026.

UBS Group held 1,964 shares of P3 Health Partners Inc Warrant worth $10 as of Q1 2026.
UBS Group sold 908 P3 Health Partners Inc Warrant shares in Q1 2026, an estimated $7.
P3 Health Partners Inc Warrant made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #10328 holding.
UBS Group first reported a position in P3 Health Partners Inc Warrant in Q1 2023 and has held it in 9 quarters since.
UBS Group's P3 Health Partners Inc Warrant position peaked at $710 in Q2 2023.
19 funds tracked by Wall St. Rank held P3 Health Partners Inc Warrant as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.